{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:33:03Z","timestamp":1787671983004,"version":"build-2736575974"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains a deadly malignancy owing to its late presentation and the limited sensitivity of current serum biomarkers and imaging for early detection. Extracellular vesicles (EVs), which carry proteins, nucleic acids, and lipids that reflect tumor\u2013stromal interactions, have emerged as promising biomarkers for early diagnosis, disease monitoring, and treatment response. Several EV-derived proteins, microRNAs, long noncoding RNAs, and DNA alterations linked to early carcinogenesis and therapeutic resistance have been identified. However, variability in pre-analytical handling and analytical platforms has hindered reproducibility. Global standardization efforts, such as European Liquid Biopsy Society (ELBS), The Blood Profiling Atlas in Cancer (BloodPAC), International Liquid Biopsy Standardization Alliance (ILSA), and Minimal information for studies of extracellular vesicles (MISEV), are currently helping to unify methodologies for EV isolation and molecular profiling. Advances in analytical technologies have shifted the field from bulk EV measurements to high-resolution single-vesicle approaches. Techniques, such as nanoflow cytometry, super-resolution imaging, Raman spectroscopy, and surface-enhanced Raman scattering, enable the detection of rare, mutation-bearing, or functionally distinct EV subpopulations, which may enhance diagnostic precision. In gastroenterology, a major opportunity lies in integrating single-EV analytics with the endoscopic sampling of tumor-proximal fluids. EVs obtained from pancreatic juice, bile, duodenal fluid, or portal venous blood via endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound (EUS) provide spatially enriched molecular information beyond peripheral blood. Combining endoscopic access with particle-level EV characterization may allow real-time, mechanism-informed assessment of tumor biology and premalignant lesions, offering a promising strategy for early detection and risk stratification in PDAC. Together, these developments have positioned EV-based liquid biopsy as a rapidly maturing field with strong translational potential.<\/jats:p>","DOI":"10.1007\/s00535-026-02350-3","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:35:42Z","timestamp":1770359742000},"page":"1234-1250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Extracellular vesicle biomarkers in pancreatic ductal adenocarcinoma: from bulk detection to single-extracellular vesicle profiling and endoscopic liquid biopsy"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-3607","authenticated-orcid":false,"given":"Nana","family":"Shimamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Sumiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"7","key":"2350_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346.","journal-title":"Int J Cancer"},{"issue":"12","key":"2350_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","volume":"4","author":"A Pourshams","year":"2019","unstructured":"Pourshams A, Sepanlou SG, Ikuta KS, Bisignano C, Safiri S, Roshandel G, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2350_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/CMAR.S172421","volume":"12","author":"J Llach","year":"2020","unstructured":"Llach J, Carballal S, Moreira L. Familial pancreatic cancer: current perspectives. Cancer Manag Res. 2020;12:743\u201358.","journal-title":"Cancer Manag Res"},{"issue":"9","key":"2350_CR4","first-page":"1084","volume":"40","author":"XH Xu","year":"2019","unstructured":"Xu XH, Zeng XY, Wang LJ, Liu YN, Liu JM, Qi JL, et al. The disease burden of pancreatic cancer in China in 1990 and 2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(9):1084\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2350_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311.","journal-title":"Cancer Lett."},{"issue":"1","key":"2350_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00001648-200301000-00013","volume":"14","author":"DT Silverman","year":"2003","unstructured":"Silverman DT, Hoover RN, Brown LM, Swanson GM, Schiffman M, Greenberg RS, et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology. 2003;14(1):45\u201354.","journal-title":"Epidemiology"},{"issue":"2","key":"2350_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s10620-021-06886-7","volume":"67","author":"S Munigala","year":"2022","unstructured":"Munigala S, Subramaniam DS, Subramaniam DP, Burroughs TE, Conwell DL, Sheth SG. Incidence and risk of pancreatic cancer in patients with a new diagnosis of chronic pancreatitis. Dig Dis Sci. 2022;67(2):708\u201315.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2350_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26411-8","volume":"13","author":"HS Kim","year":"2023","unstructured":"Kim HS, Gweon TG, Park SH, Kim TH, Kim CW, Chang JH. Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: defining the optimal subgroup for surveillance. Sci Rep. 2023;13(1):106.","journal-title":"Sci Rep"},{"key":"2350_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194684","author":"C Mellenthin","year":"2022","unstructured":"Mellenthin C, Balaban VD, Dugic A, Cullati S. Risk factors for pancreatic cancer in patients with new-onset diabetes: a systematic review and meta-analysis. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194684.","journal-title":"Cancers (Basel)"},{"key":"2350_CR10","volume":"10","author":"JF Zhao","year":"2023","unstructured":"Zhao JF, Teng QP, Lv Y, Li XY, Ding Y. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic cancer: a systematic review and meta-analysis of cohort studies. Ther Adv Infect Dis. 2023;10:20499361231212161.","journal-title":"Ther Adv Infect Dis"},{"issue":"5","key":"2350_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.gie.2021.12.001","volume":"95","author":"MS Sawhney","year":"2022","unstructured":"Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI, et al. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc. 2022;95(5):817\u201326.","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"2350_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987\u20131002.","journal-title":"Ann Oncol"},{"issue":"4","key":"2350_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","volume":"28","author":"T Okusaka","year":"2023","unstructured":"Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N, et al. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Int J Clin Oncol. 2023;28(4):493\u2013511.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2350_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7\u201317.","journal-title":"Gut"},{"issue":"7","key":"2350_CR15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1515\/cclm-2012-0744","volume":"51","author":"C Galli","year":"2013","unstructured":"Galli C, Basso D, Plebani M. CA 19-9: handle with care. Clin Chem Lab Med. 2013;51(7):1369\u201383.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2350_CR16","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1097\/MPA.0000000000002209","volume":"52","author":"A Sasaki","year":"2023","unstructured":"Sasaki A, Sakata K, Nakano K, Tsutsumi S, Fujishima H, Futsukaichi T, et al. DUPAN-2 as a Risk Factor of Early Recurrence After Curative Pancreatectomy for Patients With Pancreatic Ductal Adenocarcinoma. Pancreas. 2023;52(2):e110\u20134.","journal-title":"Pancreas"},{"issue":"18","key":"2350_CR17","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1200\/JCO.23.01573","volume":"42","author":"Y Ando","year":"2024","unstructured":"Ando Y, Dbouk M, Yoshida T, Saba H, Abou Diwan E, Yoshida K, et al. Using tumor marker gene variants to improve the diagnostic accuracy of DUPAN-2 and carbohydrate antigen 19-9 for pancreatic cancer. J Clin Oncol. 2024;42(18):2196\u2013206.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2350_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.cgh.2019.10.036","volume":"18","author":"T Abe","year":"2020","unstructured":"Abe T, Koi C, Kohi S, Song KB, Tamura K, Macgregor-Das A, et al. Gene variants that affect levels of circulating tumor markers increase identification of patients with pancreatic cancer. Clin Gastroenterol Hepatol. 2020;18(5):1161-9.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"2350_CR19","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1158\/1078-0432.CCR-23-0655","volume":"29","author":"M Dbouk","year":"2023","unstructured":"Dbouk M, Abe T, Koi C, Ando Y, Saba H, Abou Diwan E, et al. Diagnostic performance of a tumor marker gene test to personalize serum CA19-9 reference ranges. Clin Cancer Res. 2023;29(20):4178\u201385.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2350_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-018-1519-2","volume":"54","author":"M Kitano","year":"2019","unstructured":"Kitano M, Yoshida T, Itonaga M, Tamura T, Hatamaru K, Yamashita Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol. 2019;54(1):19\u201332.","journal-title":"J Gastroenterol"},{"key":"2350_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejrad.2017.04.009","volume":"92","author":"J Toft","year":"2017","unstructured":"Toft J, Hadden WJ, Laurence JM, Lam V, Yuen L, Janssen A, et al. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. Eur J Radiol. 2017;92:17\u201323.","journal-title":"Eur J Radiol"},{"issue":"10","key":"2350_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.hpb.2019.02.013","volume":"21","author":"HFA Vasen","year":"2019","unstructured":"Vasen HFA, Boekestijn B, Ibrahim IS, Inderson A, Bonsing BA, de Vos Tot Nerveen Cappel WH, et al. Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program. HPB (Oxf). 2019;21(10):1371\u20135.","journal-title":"HPB (Oxf)"},{"issue":"9","key":"2350_CR23","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/diagnostics11091693","volume":"11","author":"S Miura","year":"2021","unstructured":"Miura S, Takikawa T, Kikuta K, Hamada S, Kume K, Yoshida N, et al. Focal parenchymal atrophy of the pancreas is frequently observed on pre-diagnostic computed tomography in patients with pancreatic cancer: a case-control study. Diagnostics (Basel). 2021;11(9):1693.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"2350_CR24","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1053\/j.gastro.2019.01.039","volume":"156","author":"RP Sah","year":"2019","unstructured":"Sah RP, Sharma A, Nagpal S, Patlolla SH, Sharma A, Kandlakunta H, et al. Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma. Gastroenterology. 2019;156(6):1742\u201352.","journal-title":"Gastroenterology"},{"issue":"7711","key":"2350_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","volume":"558","author":"LV Danai","year":"2018","unstructured":"Danai LV, Babic A, Rosenthal MH, Dennstedt EA, Muir A, Lien EC, et al. Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature. 2018;558(7711):600\u20134.","journal-title":"Nature"},{"issue":"2","key":"2350_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1148\/radiol.14132563","volume":"273","author":"MJ Park","year":"2014","unstructured":"Park MJ, Kim YK, Choi SY, Rhim H, Lee WJ, Choi D. Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level. Radiology. 2014;273(2):433\u201343.","journal-title":"Radiology"},{"issue":"1","key":"2350_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.10100015","volume":"257","author":"JH Kim","year":"2010","unstructured":"Kim JH, Park SH, Yu ES, Kim MH, Kim J, Byun JH, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87\u201396.","journal-title":"Radiology"},{"key":"2350_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2024.100553","volume":"12","author":"C Bilreiro","year":"2024","unstructured":"Bilreiro C, Andrade L, Santiago I, Marques RM, Matos C. Imaging of pancreatic ductal adenocarcinoma - an update for all stages of patient management. Eur J Radiol Open. 2024;12:100553.","journal-title":"Eur J Radiol Open"},{"key":"2350_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14010078","author":"A Chatterjee","year":"2023","unstructured":"Chatterjee A, Shah J. Role of endoscopic ultrasound in diagnosis of pancreatic ductal adenocarcinoma. Diagnostics. 2023. https:\/\/doi.org\/10.3390\/diagnostics14010078.","journal-title":"Diagnostics"},{"issue":"2","key":"2350_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ajg.2011.354","volume":"107","author":"M Kitano","year":"2012","unstructured":"Kitano M, Kudo M, Yamao K, Takagi T, Sakamoto H, Komaki T, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol. 2012;107(2):303\u201310.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2350_CR31","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.22834","volume":"8","author":"L Lin","year":"2018","unstructured":"Lin L, Fan Y, Gao F, Jin L, Li D, Sun W, et al. UTMD-promoted co-delivery of gemcitabine and miR-21 inhibitor by dendrimer-entrapped gold nanoparticles for pancreatic cancer therapy. Theranostics. 2018;8(7):1923\u201339.","journal-title":"Theranostics"},{"issue":"1","key":"2350_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/eus.eus_43_18","volume":"8","author":"N Shimamoto","year":"2019","unstructured":"Shimamoto N, Imazu H, Homma S, Sumiyama K. Vascular endothelial growth factor receptor 2-targeted ultrasound contrast agent selectively accumulates in pancreatic carcinoma in the allograft mouse model: a pilot study using time-intensity curve analysis of EUS imaging. Endosc Ultrasound. 2019;8(1):69\u201371.","journal-title":"Endosc Ultrasound"},{"issue":"5","key":"2350_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.hbpd.2020.03.004","volume":"19","author":"N Shimamoto","year":"2020","unstructured":"Shimamoto N, Ito M, Chiba M, Honma S, Imazu H, Sumiyama K. Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: in vivo mouse pancreatic ductal adenocarcinoma model. Hepatobiliary Pancreat Dis Int. 2020;19(5):478\u201385.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"11","key":"2350_CR34","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/1878-0261.13643","volume":"18","author":"G Zhao","year":"2024","unstructured":"Zhao G, Jiang R, Shi Y, Gao S, Wang D, Li Z, et al. Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma. Mol Oncol. 2024;18(11):2801\u201313.","journal-title":"Mol Oncol"},{"issue":"1","key":"2350_CR35","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1038\/s41467-025-61890-z","volume":"16","author":"J Wu","year":"2025","unstructured":"Wu J, Xu X, Zhang Q, Li P, Wu T, Guo S, et al. Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer. Nat Commun. 2025;16(1):6645.","journal-title":"Nat Commun"},{"issue":"6","key":"2350_CR36","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jmoldx.2020.02.010","volume":"22","author":"A Macgregor-Das","year":"2020","unstructured":"Macgregor-Das A, Yu J, Tamura K, Abe T, Suenaga M, Shindo K, et al. Detection of circulating tumor DNA in patients with pancreatic cancer using digital next-generation sequencing. J Mol Diagn. 2020;22(6):748\u201356.","journal-title":"J Mol Diagn"},{"issue":"11","key":"2350_CR37","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.dld.2023.03.011","volume":"55","author":"C Evrard","year":"2023","unstructured":"Evrard C, Ingrand P, Rochelle T, Martel M, Tachon G, Flores N, et al. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: the KRASCIPANC prospective study. Dig Liver Dis. 2023;55(11):1562\u201372.","journal-title":"Dig Liver Dis"},{"key":"2350_CR38","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/1078-0432.CCR-25-0758","volume":"31","author":"MM Steiniche","year":"2025","unstructured":"Steiniche MM, Lindgaard SC, Chen IM, Johansen JS, Andersen RF, Hansen TF, et al. The prognostic impact of early ctDNA kinetics in metastatic pancreatic cancer using the ctDNA Response Evaluation Criteria in Solid Tumors (ctDNA-RECIST). Clin Cancer Res. 2025;31:4720\u20139.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2350_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.7150\/ijms.52706","volume":"18","author":"C Peng","year":"2021","unstructured":"Peng C, Wang J, Gao W, Huang L, Liu Y, Li X, et al. Meta-analysis of the diagnostic performance of circulating MicroRNAs for pancreatic cancer. Int J Med Sci. 2021;18(3):660\u201371.","journal-title":"Int J Med Sci"},{"issue":"3","key":"2350_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ijc.34956","volume":"155","author":"C Wang","year":"2024","unstructured":"Wang C, Cai H, Cai Q, Wu J, Stolzenberg-Solomon R, Guo X, et al. Circulating microRNAs in association with pancreatic cancer risk within 5\u2009years. Int J Cancer. 2024;155(3):519\u201331.","journal-title":"Int J Cancer"},{"issue":"4","key":"2350_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100552","volume":"7","author":"I Hartlapp","year":"2022","unstructured":"Hartlapp I, Valta-Seufzer D, Siveke JT, Alg\u00fcl H, Goekkurt E, Siegler G, et al. Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113). ESMO Open. 2022;7(4):100552.","journal-title":"ESMO Open"},{"issue":"18","key":"2350_CR42","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","volume":"24","author":"CR Ferrone","year":"2006","unstructured":"Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006;24(18):2897\u2013902.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2350_CR43","first-page":"166","volume":"5","author":"MD Chuong","year":"2014","unstructured":"Chuong MD, Boggs DH, Patel KN, Regine WF. Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us? J Gastrointest Oncol. 2014;5(3):166\u201377.","journal-title":"J Gastrointest Oncol"},{"key":"2350_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah5583","author":"J Kim","year":"2017","unstructured":"Kim J, Bamlet WR, Oberg AL, Chaffee KG, Donahue G, Cao XJ, et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aah5583.","journal-title":"Sci Transl Med"},{"issue":"4","key":"2350_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/jnci\/djy126","volume":"111","author":"JF Fahrmann","year":"2019","unstructured":"Fahrmann JF, Bantis LE, Capello M, Scelo G, Dennison JB, Patel N, et al. A plasma-derived protein-metabolite multiplexed panel for early-stage pancreatic cancer. J Natl Cancer Inst. 2019;111(4):372\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2350_CR46","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000468","volume":"13","author":"RE Brand","year":"2022","unstructured":"Brand RE, Persson J, Bratlie SO, Chung DC, Katona BW, Carrato A, et al. Detection of early-stage pancreatic ductal adenocarcinoma from blood samples: results of a multiplex biomarker signature validation study. Clin Transl Gastroenterol. 2022;13(3):e00468.","journal-title":"Clin Transl Gastroenterol"},{"issue":"116","key":"2350_CR47","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.14309\/01.ajg.0000772012.10215.fb","volume":"S8","author":"TCM King","year":"2021","unstructured":"King TCM. The IMMray PanCan-d Test Performance and CA19\u20139: results from the blind validation study. Am J Gastroenterol. 2021;S8(116):S4.","journal-title":"Am J Gastroenterol"},{"key":"2350_CR48","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00445","volume":"7","author":"BW Katona","year":"2023","unstructured":"Katona BW, Worthington C, Clay D, Cincotta H, Ahmad NA, Ginsberg GG, et al. Outcomes of the IMMray PanCan-d test in high-risk individuals undergoing pancreatic surveillance: pragmatic data and lessons learned. JCO Precis Oncol. 2023;7:e2300445.","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"2350_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.34287","volume":"152","author":"S Debernardi","year":"2023","unstructured":"Debernardi S, Blyuss O, Rycyk D, Srivastava K, Jeon CY, Cai H, et al. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. Int J Cancer. 2023;152(4):769\u201380.","journal-title":"Int J Cancer"},{"issue":"12","key":"2350_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003489","volume":"17","author":"S Debernardi","year":"2020","unstructured":"Debernardi S, O\u2019Brien H, Algahmdi AS, Malats N, Stewart GD, Plje\u0161a-Ercegovac M, et al. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study. PLoS Med. 2020;17(12):e1003489.","journal-title":"PLoS Med"},{"issue":"4","key":"2350_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/CBM-160595","volume":"16","author":"P Hogendorf","year":"2016","unstructured":"Hogendorf P, Durczy\u0144ski A, Skulimowski A, Kumor A, Pozna\u0144ska G, Strzelczyk J. Neutrophil gelatinase-associated lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: preliminary report. Cancer Biomark. 2016;16(4):537\u201343.","journal-title":"Cancer Biomark"},{"issue":"6","key":"2350_CR52","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/ijc.33368","volume":"148","author":"S Sahni","year":"2021","unstructured":"Sahni S, Pandya AR, Hadden WJ, Nahm CB, Maloney S, Cook V, et al. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma. Int J Cancer. 2021;148(6):1508\u201318.","journal-title":"Int J Cancer"},{"issue":"3","key":"2350_CR53","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1053\/j.gastro.2009.11.010","volume":"138","author":"L Zhang","year":"2010","unstructured":"Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138(3):949\u201357.","journal-title":"Gastroenterology"},{"issue":"2","key":"2350_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1940-6207.CAPR-14-0192","volume":"8","author":"Z Xie","year":"2015","unstructured":"Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila). 2015;8(2):165\u201373.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"2350_CR55","volume":"16","author":"H Al Balushi","year":"2024","unstructured":"Al Balushi H, Chowdhury P, Babu HM, Rehman A, Bokhari SFH, Al-Tarawneh LM, et al. The potential of salivary biomarkers in early detection of pancreatic ductal adenocarcinoma: a systematic review. Cureus. 2024;16(2):e55003.","journal-title":"Cureus"},{"issue":"12","key":"2350_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13848","volume":"52","author":"M Koopaie","year":"2022","unstructured":"Koopaie M, Kolahdooz S, Fatahzadeh M, Aleedawi ZA. Salivary noncoding RNA in the diagnosis of pancreatic cancer: systematic review and meta-analysis. Eur J Clin Invest. 2022;52(12):e13848.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2350_CR57","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56(4):836\u201349.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2350_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01408-6","volume":"22","author":"K H\u00e1n\u011blov\u00e1","year":"2024","unstructured":"H\u00e1n\u011blov\u00e1 K, Raudensk\u00e1 M, Masa\u0159\u00edk M, Balvan J. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. Cell Commun Signal. 2024;22(1):25.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2350_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64718-6","volume":"10","author":"KA Servage","year":"2020","unstructured":"Servage KA, Stefanius K, Gray HF, Orth K. Proteomic profiling of small extracellular vesicles secreted by human pancreatic cancer cells implicated in cellular transformation. Sci Rep. 2020;10(1):7713.","journal-title":"Sci Rep"},{"issue":"1","key":"2350_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64248-1","volume":"10","author":"N Kren","year":"2020","unstructured":"Kren N, Michaud D, Bagchi S, Greene K, Pylayeva-Gupta Y. Rab27a plays a dual role in metastatic propensity of pancreatic cancer. Sci Rep. 2020;10(1):7390.","journal-title":"Sci Rep"},{"issue":"7578","key":"2350_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329\u201335.","journal-title":"Nature"},{"issue":"6","key":"2350_CR62","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816\u201326.","journal-title":"Nat Cell Biol"},{"key":"2350_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F, P\u00e9rez-Hern\u00e1ndez D, V\u00e1zquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.","journal-title":"Nat Commun"},{"key":"2350_CR64","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19276","author":"MJ Shurtleff","year":"2016","unstructured":"Shurtleff MJ, Temoche-Diaz MM, Karfilis KV, Ri S, Schekman R. Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.19276.","journal-title":"Elife"},{"issue":"3","key":"2350_CR65","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","volume":"17","author":"L Santangelo","year":"2016","unstructured":"Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, et al. The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Rep. 2016;17(3):799\u2013808.","journal-title":"Cell Rep"},{"key":"2350_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157644","author":"Y Luo","year":"2022","unstructured":"Luo Y, Li Z, Kong Y, He W, Zheng H, An M, et al. KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI157644.","journal-title":"J Clin Invest"},{"issue":"16","key":"2350_CR67","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","volume":"78","author":"X Wang","year":"2018","unstructured":"Wang X, Luo G, Zhang K, Cao J, Huang C, Jiang T, et al. Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K\u03b3 to promote pancreatic cancer metastasis. Cancer Res. 2018;78(16):4586\u201398.","journal-title":"Cancer Res"},{"key":"2350_CR68","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.24641","author":"LA Mulcahy","year":"2014","unstructured":"Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014. https:\/\/doi.org\/10.3402\/jev.v3.24641.","journal-title":"J Extracell Vesicles"},{"key":"2350_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.570108","volume":"10","author":"S Song","year":"2020","unstructured":"Song S, Zhang Y, Ding T, Ji N, Zhao H. The dual role of macropinocytosis in cancers: promoting growth and inducing methuosis to participate in anticancer therapies as targets. Front Oncol. 2020;10:570108.","journal-title":"Front Oncol"},{"issue":"1","key":"2350_CR70","first-page":"14","volume":"11","author":"F Xiao","year":"2021","unstructured":"Xiao F, Li J, Huang K, Li X, Xiong Y, Wu M, et al. Macropinocytosis: mechanism and targeted therapy in cancers. Am J Cancer Res. 2021;11(1):14\u201330.","journal-title":"Am J Cancer Res"},{"issue":"7451","key":"2350_CR71","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497(7451):633\u20137.","journal-title":"Nature"},{"issue":"7659","key":"2350_CR72","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503.","journal-title":"Nature"},{"key":"2350_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184332","author":"B Lan","year":"2019","unstructured":"Lan B, Zeng S, Gr\u00fctzmann R, Pilarsky C. The role of exosomes in pancreatic cancer. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20184332.","journal-title":"Int J Mol Sci"},{"key":"2350_CR74","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2016.01.07","volume":"1","author":"L Lorenzon","year":"2016","unstructured":"Lorenzon L, Blandino G. Glypican-1 exosomes: do they initiate a new era for early pancreatic cancer diagnosis? Transl Gastroenterol Hepatol. 2016;1:8.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"38","key":"2350_CR75","doi-asserted-by":"publisher","first-page":"63461","DOI":"10.18632\/oncotarget.18831","volume":"8","author":"Z Yu","year":"2017","unstructured":"Yu Z, Zhao S, Ren L, Wang L, Chen Z, Hoffman RM, et al. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation. Oncotarget. 2017;8(38):63461\u201383.","journal-title":"Oncotarget"},{"issue":"8","key":"2350_CR76","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.ymthe.2024.06.030","volume":"32","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Feng Y, Sun F, Li L, Chen J, Song Y, et al. Optimized rAAV8 targeting acinar KLF4 ameliorates fibrosis in chronic pancreatitis via exosomes-enriched let-7s suppressing pancreatic stellate cells activation. Mol Ther. 2024;32(8):2624\u201340.","journal-title":"Mol Ther"},{"issue":"1","key":"2350_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45753-7","volume":"15","author":"B Adem","year":"2024","unstructured":"Adem B, Bastos N, Ruivo CF, Sousa-Alves S, Dias C, Vieira PF, et al. Exosomes define a local and systemic communication network in healthy pancreas and pancreatic ductal adenocarcinoma. Nat Commun. 2024;15(1):1496.","journal-title":"Nat Commun"},{"issue":"3","key":"2350_CR78","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.7150\/ijbs.67675","volume":"18","author":"K Chen","year":"2022","unstructured":"Chen K, Wang Q, Liu X, Wang F, Yang Y, Tian X. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression. Int J Biol Sci. 2022;18(3):1220\u201337.","journal-title":"Int J Biol Sci"},{"key":"2350_CR79","doi-asserted-by":"publisher","first-page":"7752277","DOI":"10.1155\/2022\/7752277","volume":"2022","author":"G Wu","year":"2022","unstructured":"Wu G, Ding X, Quan G, Xiong J, Li Q, Li Z, et al. Hypoxia-induced miR-210 promotes endothelial cell permeability and angiogenesis via exosomes in pancreatic ductal adenocarcinoma. Biochem Res Int. 2022;2022:7752277.","journal-title":"Biochem Res Int"},{"issue":"1","key":"2350_CR80","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/jcmm.14766","volume":"24","author":"D Shang","year":"2020","unstructured":"Shang D, Xie C, Hu J, Tan J, Yuan Y, Liu Z, et al. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2. J Cell Mol Med. 2020;24(1):588\u2013604.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2350_CR81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13577-024-01144-0","volume":"38","author":"T Wang","year":"2024","unstructured":"Wang T, Ye L, Zhou Y, Zhang X, Li R, Zhou Y, et al. Pancreatic cancer-derived exosomal miR-510 promotes macrophage M2 polarization and facilitates cancer cell aggressive phenotypes. Hum Cell. 2024;38(1):17.","journal-title":"Hum Cell"},{"issue":"11","key":"2350_CR82","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","volume":"16","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16(11):2069\u201383.","journal-title":"Autophagy"},{"key":"2350_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9514697","volume":"2022","author":"M Zhao","year":"2022","unstructured":"Zhao M, Zhuang A, Fang Y. Cancer-associated fibroblast-derived exosomal miRNA-320a promotes macrophage M2 polarization in vitro by regulating PTEN\/PI3K\u03b3 signaling in pancreatic cancer. J Oncol. 2022;2022:9514697.","journal-title":"J Oncol"},{"issue":"7","key":"2350_CR84","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-14-2022","volume":"21","author":"N Javeed","year":"2015","unstructured":"Javeed N, Sagar G, Dutta SK, Smyrk TC, Lau JS, Bhattacharya S, et al. Pancreatic cancer-derived exosomes cause paraneoplastic \u03b2-cell dysfunction. Clin Cancer Res. 2015;21(7):1722\u201333.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2350_CR85","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.7150\/ijbs.56271","volume":"17","author":"W Pang","year":"2021","unstructured":"Pang W, Yao W, Dai X, Zhang A, Hou L, Wang L, et al. Pancreatic cancer-derived exosomal microRNA-19a induces \u03b2-cell dysfunction by targeting ADCY1 and EPAC2. Int J Biol Sci. 2021;17(13):3622\u201333.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2350_CR86","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s11033-021-06980-z","volume":"49","author":"J Su","year":"2022","unstructured":"Su J, Pang W, Zhang A, Li L, Yao W, Dai X. Exosomal miR-19a decreases insulin production by targeting Neurod1 in pancreatic cancer associated diabetes. Mol Biol Rep. 2022;49(3):1711\u201320.","journal-title":"Mol Biol Rep"},{"key":"2350_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106364","volume":"183","author":"C Liu","year":"2022","unstructured":"Liu C, He D, Li L, Zhang S, Wang L, Fan Z, et al. Extracellular vesicles in pancreatic cancer immune escape: emerging roles and mechanisms. Pharmacol Res. 2022;183:106364.","journal-title":"Pharmacol Res"},{"key":"2350_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153731","author":"B Ormseth","year":"2022","unstructured":"Ormseth B, Onuma A, Zhang H, Tsung A. The hepatic pre-metastatic niche. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14153731.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2350_CR89","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/bjc.2017.18","volume":"116","author":"GK Patel","year":"2017","unstructured":"Patel GK, Khan MA, Bhardwaj A, Srivastava SK, Zubair H, Patton MC, et al. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme. DCK Br J Cancer. 2017;116(5):609\u201319.","journal-title":"DCK Br J Cancer"},{"issue":"24","key":"2350_CR90","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1002\/cam4.4830","volume":"11","author":"Y Pan","year":"2022","unstructured":"Pan Y, Tang H, Li Q, Chen G, Li D. Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Med. 2022;11(24):4979\u201388.","journal-title":"Cancer Med"},{"key":"2350_CR91","doi-asserted-by":"publisher","first-page":"42339","DOI":"10.1038\/srep42339","volume":"7","author":"M Mikamori","year":"2017","unstructured":"Mikamori M, Yamada D, Eguchi H, Hasegawa S, Kishimoto T, Tomimaru Y, et al. MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7:42339.","journal-title":"Sci Rep"},{"key":"2350_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.844648","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Li K, Li M, Lin X, Mei Y, Huang X, et al. Chemoresistance transmission via exosome-transferred MMP14 in pancreatic cancer. Front Oncol. 2022;12:844648.","journal-title":"Front Oncol"},{"issue":"1","key":"2350_CR93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13402-019-00476-6","volume":"43","author":"Z Yang","year":"2020","unstructured":"Yang Z, Zhao N, Cui J, Wu H, Xiong J, Peng T. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210. Cell Oncol (Dordr). 2020;43(1):123\u201336.","journal-title":"Cell Oncol (Dordr)"},{"issue":"7559","key":"2350_CR94","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","volume":"523","author":"SA Melo","year":"2015","unstructured":"Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177\u201382.","journal-title":"Nature"},{"issue":"5","key":"2350_CR95","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/labmed\/lmae013","volume":"55","author":"Z Qiao","year":"2024","unstructured":"Qiao Z, Wang E, Bao B, Tan X, Chen H, Wang D, et al. Diagnostic and prognostic value of circulating exosomal glypican-1 in pancreatic cancer: a meta-analysis. Lab Med. 2024;55(5):543\u201352.","journal-title":"Lab Med"},{"issue":"27","key":"2350_CR96","doi-asserted-by":"publisher","first-page":"19006","DOI":"10.18632\/oncotarget.24873","volume":"9","author":"AE Frampton","year":"2018","unstructured":"Frampton AE, Prado MM, L\u00f3pez-Jim\u00e9nez E, Fajardo-Puerta AB, Jawad ZAR, Lawton P, et al. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Oncotarget. 2018;9(27):19006\u201313.","journal-title":"Oncotarget"},{"issue":"1","key":"2350_CR97","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12885-022-09463-x","volume":"22","author":"E Jia","year":"2022","unstructured":"Jia E, Ren N, Shi X, Zhang R, Yu H, Yu F, et al. Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis. BMC Cancer. 2022;22(1):573.","journal-title":"BMC Cancer"},{"issue":"1","key":"2350_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02739-5","volume":"30","author":"H Yu","year":"2025","unstructured":"Yu H, Xin C, Zhou Y, Ding X. Advances in the application of extracellular vesicles in precise diagnosis of pancreatic cancer. Eur J Med Res. 2025;30(1):478.","journal-title":"Eur J Med Res"},{"issue":"2","key":"2350_CR99","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1158\/1541-7786.MCR-19-0588","volume":"18","author":"D Xiao","year":"2020","unstructured":"Xiao D, Dong Z, Zhen L, Xia G, Huang X, Wang T, et al. Combined exosomal GPC1, CD82, and serum CA19-9 as multiplex targets: a specific, sensitive, and reproducible detection panel for the diagnosis of pancreatic cancer. Mol Cancer Res. 2020;18(2):300\u201310.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"2350_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306373","volume":"11","author":"H Li","year":"2024","unstructured":"Li H, Chiang CL, Kwak KJ, Wang X, Doddi S, Ramanathan LV, et al. Extracellular vesicular analysis of Glypican 1 mRNA and protein for pancreatic cancer diagnosis and prognosis. Adv Sci (Weinh). 2024;11(11):e2306373.","journal-title":"Adv Sci (Weinh)"},{"key":"2350_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212191","author":"L Toracchio","year":"2024","unstructured":"Toracchio L, Carrabotta M, Mancarella C, Morrione A, Scotlandi K. EphA2 in cancer: molecular complexity and therapeutic opportunities. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252212191.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2350_CR102","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/MPA.0000000000001660","volume":"49","author":"Q Wei","year":"2020","unstructured":"Wei Q, Zhang J, Li Z, Wei L, Ren L. Serum Exo-EphA2 as a potential diagnostic biomarker for pancreatic cancer. Pancreas. 2020;49(9):1213\u20139.","journal-title":"Pancreas"},{"key":"2350_CR103","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.2147\/CMAR.S304719","volume":"13","author":"Q Wei","year":"2021","unstructured":"Wei Q, Li Z, Feng H, Ren L. Serum exosomal EphA2 is a prognostic biomarker in patients with pancreatic cancer. Cancer Manag Res. 2021;13:3675\u201383.","journal-title":"Cancer Manag Res"},{"issue":"21","key":"2350_CR104","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.7150\/thno.26650","volume":"8","author":"J Fan","year":"2018","unstructured":"Fan J, Wei Q, Koay EJ, Liu Y, Ning B, Bernard PW, et al. Chemoresistance transmission via exosome-mediated EphA2 transfer in pancreatic cancer. Theranostics. 2018;8(21):5986\u201394.","journal-title":"Theranostics"},{"key":"2350_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16122179","author":"PK Tiwari","year":"2024","unstructured":"Tiwari PK, Shanmugam P, Karn V, Gupta S, Mishra R, Rustagi S, et al. Extracellular vesicular miRNA in pancreatic cancer: from lab to therapy. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16122179.","journal-title":"Cancers (Basel)"},{"key":"2350_CR106","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2017.02.019","volume":"393","author":"X Lai","year":"2017","unstructured":"Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Cancer Lett. 2017;393:86\u201393.","journal-title":"Cancer Lett"},{"issue":"5","key":"2350_CR107","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, et al. An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter Cohort Study. Gastroenterology. 2022;163(5):1252-66.e2.","journal-title":"Gastroenterology"},{"issue":"18","key":"2350_CR108","doi-asserted-by":"publisher","first-page":"25408","DOI":"10.18632\/oncotarget.8323","volume":"7","author":"Z Xie","year":"2016","unstructured":"Xie Z, Chen X, Li J, Guo Y, Li H, Pan X, et al. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer. Oncotarget. 2016;7(18):25408\u201319.","journal-title":"Oncotarget"},{"issue":"1","key":"2350_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59523-0","volume":"10","author":"SR Kumar","year":"2020","unstructured":"Kumar SR, Kimchi ET, Manjunath Y, Gajagowni S, Stuckel AJ, Kaifi JT. RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions. Sci Rep. 2020;10(1):2800.","journal-title":"Sci Rep"},{"issue":"1","key":"2350_CR110","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/cas.14232","volume":"111","author":"K Takahashi","year":"2020","unstructured":"Takahashi K, Ota Y, Kogure T, Suzuki Y, Iwamoto H, Yamakita K, et al. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Cancer Sci. 2020;111(1):98\u2013111.","journal-title":"Cancer Sci"},{"issue":"1","key":"2350_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12755-z","volume":"24","author":"X He","year":"2024","unstructured":"He X, Chen L, Di Y, Li W, Zhang X, Bai Z, et al. Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease. BMC Cancer. 2024;24(1):961.","journal-title":"BMC Cancer"},{"issue":"6","key":"2350_CR112","first-page":"2671","volume":"53","author":"X Liang","year":"2018","unstructured":"Liang X, Qi M, Wu R, Liu A, Chen D, Tang L, et al. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways. Int J Oncol. 2018;53(6):2671\u201382.","journal-title":"Int J Oncol"},{"issue":"1","key":"2350_CR113","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/cbin.11703","volume":"46","author":"X Fang","year":"2022","unstructured":"Fang X, Cai Y, Xu Y, Zhang H. Exosome-mediated lncRNA SNHG11 regulates angiogenesis in pancreatic carcinoma through miR-324-3p\/VEGFA axis. Cell Biol Int. 2022;46(1):106\u201317.","journal-title":"Cell Biol Int"},{"issue":"1","key":"2350_CR114","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12935-022-02741-5","volume":"22","author":"J Yao","year":"2022","unstructured":"Yao J, Gao R, Luo M, Li D, Guo L, Yu Z, et al. Exosomal LINC00460\/miR-503-5p\/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint. Cancer Cell Int. 2022;22(1):390.","journal-title":"Cancer Cell Int"},{"issue":"28","key":"2350_CR115","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/s41388-018-0237-9","volume":"37","author":"Z Li","year":"2018","unstructured":"Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang X, et al. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Oncogene. 2018;37(28):3822\u201338.","journal-title":"Oncogene"},{"issue":"6","key":"2350_CR116","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.7150\/jca.81320","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Min J, Xu C, Liu Y, Yu Z, Gong A, et al. Hypoxia-elicited exosomes promote the chemoresistance of pancreatic cancer cells by transferring LncROR via Hippo signaling. J Cancer. 2023;14(6):1075\u201387.","journal-title":"J Cancer"},{"issue":"7","key":"2350_CR117","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem. 2014;289(7):3869\u201375.","journal-title":"J Biol Chem"},{"issue":"3","key":"2350_CR118","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/15384047.2017.1281499","volume":"18","author":"S Yang","year":"2017","unstructured":"Yang S, Che SP, Kurywchak P, Tavormina JL, Gansmo LB, de Correa Sampaio P, et al. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer. Cancer Biol Ther. 2017;18(3):158\u201365.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"2350_CR119","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/annonc\/mdx004","volume":"28","author":"K Allenson","year":"2017","unstructured":"Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol. 2017;28(4):741\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"2350_CR120","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2018.09.022","volume":"156","author":"V Bernard","year":"2019","unstructured":"Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, et al. Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer. Gastroenterology. 2019;156(1):108-18.e4.","journal-title":"Gastroenterology"},{"issue":"1","key":"2350_CR121","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s43856-023-00351-4","volume":"3","author":"JP Hinestrosa","year":"2023","unstructured":"Hinestrosa JP, Sears RC, Dhani H, Lewis JM, Schroeder G, Balcer HI, et al. Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma. Commun Med (Lond). 2023;3(1):146.","journal-title":"Commun Med (Lond)"},{"key":"2350_CR122","doi-asserted-by":"publisher","first-page":"RP87369","DOI":"10.7554\/eLife.87369","volume":"12","author":"B Bockorny","year":"2024","unstructured":"Bockorny B, Muthuswamy L, Huang L, Hadisurya M, Maria Lim C, Tsai LL, et al. A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. Elife. 2024;12:RP87369.","journal-title":"Elife"},{"key":"2350_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4591","volume":"5","author":"Y Yoshioka","year":"2014","unstructured":"Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using exoscreen. Nat Commun. 2014;5:3591.","journal-title":"Nat Commun"},{"issue":"4","key":"2350_CR124","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/acsnano.7b08199","volume":"12","author":"JM Lewis","year":"2018","unstructured":"Lewis JM, Vyas AD, Qiu Y, Messer KS, White R, Heller MJ. Integrated analysis of exosomal protein biomarkers on alternating current electrokinetic chips enables rapid detection of pancreatic cancer in patient blood. ACS Nano. 2018;12(4):3311\u201320.","journal-title":"ACS Nano"},{"issue":"29","key":"2350_CR125","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1111\/1759-7714.15077","volume":"14","author":"M Torasawa","year":"2023","unstructured":"Torasawa M, Horinouchi H, Yagishita S, Utsumi H, Okuda K, Takekoshi D, et al. Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesicles. Thorac Cancer. 2023;14(29):2909\u201323.","journal-title":"Thorac Cancer"},{"key":"2350_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108732","volume":"208","author":"H Utsumi","year":"2025","unstructured":"Utsumi H, Yagishita S, Kawajiri K, Torasawa M, Kiritani A, Tamura K, et al. Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer. Lung Cancer. 2025;208:108732.","journal-title":"Lung Cancer"},{"issue":"5","key":"2350_CR127","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1097\/MPA.0000000000002315","volume":"53","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Inuzuka T, Shimizu Y, Sawamoto K, Taniue K, Ono Y, et al. Liquid biopsy for pancreatic cancer by serum extracellular vesicle-encapsulated long noncoding RNA HEVEPA. Pancreas. 2024;53(5):e395\u2013404.","journal-title":"Pancreas"},{"issue":"1","key":"2350_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03398-4","volume":"44","author":"K Pantel","year":"2025","unstructured":"Pantel K, Alix-Panabi\u00e8res C, Hofman P, Stoecklein NH, Lu YJ, Lianidou E, et al. Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS). J Exp Clin Cancer Res. 2025;44(1):156.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2350_CR129","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cpt.3416","volume":"117","author":"CM Lockwood","year":"2025","unstructured":"Lockwood CM, Merker JD, Bain E, Compton C, Grossman RL, Johann D, et al. Towards preanalytical best practices for liquid biopsy studies: a BLOODPAC landscape analysis. Clin Pharmacol Ther. 2025;117(1):28\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"2350_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103112","volume":"156","author":"D Connors","year":"2020","unstructured":"Connors D, Allen J, Alvarez JD, Boyle J, Cristofanilli M, Hiller C, et al. International liquid biopsy standardization alliance white paper. Crit Rev Oncol Hematol. 2020;156:103112.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2350_CR131","unstructured":"H.U.\u4e2d\u592e\u7814\u7a76\u6240\u304c\u300c\u81b5\u304c\u3093\u65e9\u671f\u8a3a\u65ad\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0\u300d\u3092\u767a\u8db3 2025."},{"issue":"8","key":"2350_CR132","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.molmed.2022.05.003","volume":"28","author":"S Ferguson","year":"2022","unstructured":"Ferguson S, Yang KS, Weissleder R. Single extracellular vesicle analysis for early cancer detection. Trends Mol Med. 2022;28(8):681\u201392.","journal-title":"Trends Mol Med"},{"key":"2350_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/bios13010129","author":"L Qiu","year":"2023","unstructured":"Qiu L, Liu X, Zhu L, Luo L, Sun N, Pei R. Current advances in technologies for single extracellular vesicle analysis and its clinical applications in cancer diagnosis. Biosensors. 2023. https:\/\/doi.org\/10.3390\/bios13010129.","journal-title":"Biosensors"},{"issue":"16","key":"2350_CR134","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm3453","volume":"8","author":"S Ferguson","year":"2022","unstructured":"Ferguson S, Yang KS, Zelga P, Liss AS, Carlson JCT, Del Castillo CF, et al. Single-EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer. Sci Adv. 2022;8(16):eabm3453.","journal-title":"Sci Adv"},{"key":"2350_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.628346","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang Y, Gao X, Yuan Y, Zhao J, Zhou S, et al. Plasma-derived exosomal ALIX as a novel biomarker for diagnosis and classification of pancreatic cancer. Front Oncol. 2021;11:628346.","journal-title":"Front Oncol"},{"issue":"1","key":"2350_CR136","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1685634","volume":"8","author":"KM Lennon","year":"2019","unstructured":"Lennon KM, Wakefield DL, Maddox AL, Brehove MS, Willner AN, Garcia-Mansfield K, et al. Single molecule characterization of individual extracellular vesicles from pancreatic cancer. J Extracell Vesicles. 2019;8(1):1685634.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2350_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37403-1","volume":"14","author":"H Shin","year":"2023","unstructured":"Shin H, Choi BH, Shim O, Kim J, Park Y, Cho SK, et al. Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers. Nat Commun. 2023;14(1):1644.","journal-title":"Nat Commun"},{"issue":"9","key":"2350_CR138","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1136\/gutjnl-2015-311166","volume":"66","author":"J Yu","year":"2017","unstructured":"Yu J, Sadakari Y, Shindo K, Suenaga M, Brant A, Almario JAN, et al. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Gut. 2017;66(9):1677\u201387.","journal-title":"Gut"},{"key":"2350_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020375","author":"K Satoh","year":"2021","unstructured":"Satoh K. Molecular approaches using body fluid for the early detection of pancreatic cancer. Diagnostics. 2021. https:\/\/doi.org\/10.3390\/diagnostics11020375.","journal-title":"Diagnostics"},{"issue":"1","key":"2350_CR140","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MPA.0000000000000956","volume":"47","author":"M Suenaga","year":"2018","unstructured":"Suenaga M, Dudley B, Karloski E, Borges M, Irene Canto M, Brand RE, et al. The effect of pancreatic juice collection time on the detection of KRAS mutations. Pancreas. 2018;47(1):35\u20139.","journal-title":"Pancreas"},{"key":"2350_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.961939","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Liu Y, Fu J, Mugaanyi J, Yan J, Lu C, et al. Bile is a reliable and valuable source to study cfDNA in biliary tract cancers. Front Oncol. 2022;12:961939.","journal-title":"Front Oncol"},{"key":"2350_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010039","author":"C Driescher","year":"2020","unstructured":"Driescher C, Fuchs K, Haeberle L, Goering W, Frohn L, Opitz FV, et al. Bile-based cell-free DNA analysis is a reliable diagnostic tool in pancreatobiliary cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers13010039.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2350_CR143","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1136\/gutjnl-2021-325178","volume":"71","author":"M Arechederra","year":"2022","unstructured":"Arechederra M, Rull\u00e1n M, Amat I, Oyon D, Zabalza L, Elizalde M, et al. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures. Gut. 2022;71(6):1141\u201351.","journal-title":"Gut"},{"key":"2350_CR144","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006645","author":"S Yachida","year":"2025","unstructured":"Yachida S, Yoshinaga S, Shiba S, Urabe M, Tanaka H, Takeda Y, et al. KRAS mutations in duodenal lavage fluid after secretin stimulation for detection of pancreatic cancer. Ann Surg. 2025. https:\/\/doi.org\/10.1097\/SLA.0000000000006645.","journal-title":"Ann Surg"},{"issue":"1","key":"2350_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.333","volume":"4","author":"T Taniguchi","year":"2024","unstructured":"Taniguchi T, Ideno N, Araki T, Miura S, Yamamoto M, Nakafusa T, et al. MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenocarcinoma. DEN Open. 2024;4(1):e333.","journal-title":"DEN Open"},{"issue":"7","key":"2350_CR146","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1053\/j.gastro.2015.08.050","volume":"149","author":"DV Catenacci","year":"2015","unstructured":"Catenacci DV, Chapman CG, Xu P, Koons A, Konda VJ, Siddiqui UD, et al. Acquisition of portal venous circulating tumor cells from patients with pancreaticobiliary cancers by endoscopic ultrasound. Gastroenterology. 2015;149(7):1794-803.e4.","journal-title":"Gastroenterology"},{"key":"2350_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081986","author":"V Heredia-Soto","year":"2021","unstructured":"Heredia-Soto V, Rodr\u00edguez-Salas N, Feliu J. Liquid biopsy in pancreatic cancer: are we ready to apply it in the clinical practice? Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13081986.","journal-title":"Cancers (Basel)"},{"key":"2350_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1705162","volume":"15","author":"G Wu","year":"2025","unstructured":"Wu G, Xu X, Zhang H, Peng L, Liu C. Liquid biopsy in biliary tract cancers: early diagnosis, precision therapy, and prognostic evaluation. Front Oncol. 2025;15:1705162.","journal-title":"Front Oncol"},{"key":"2350_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158436","author":"F Tavano","year":"2024","unstructured":"Tavano F, Latiano A, Palmieri O, Gioffreda D, Latiano T, Gentile A, et al. Duodenal fluid analysis as a rewarding approach to detect low-abundance mutations in biliopancreatic cancers. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158436.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02350-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:08:03Z","timestamp":1787670483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":149,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2350"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02350-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}